专题：Neutropenia and Cancer Infections

This cluster of papers focuses on the management of febrile neutropenia in cancer patients, particularly those with hematological malignancies receiving chemotherapy. It includes clinical practice guidelines, updates on antimicrobial agents, use of granulocyte colony-stimulating factor, risk assessment tools, prophylactic strategies, and the impact of febrile neutropenia on morbidity and mortality.
最新文献
Clinical profile, treatment, and outcomes of febrile neutropenia in hematologic disorders: a look at 30-day mortality predictors

article Full Text OpenAlex

Prevalence of Pancytopenia among HIV Patients Attended to HIV Center in Sana'a City

article Full Text OpenAlex

Neutropenic patient with acute severe epigastric pain

article Full Text OpenAlex

Febrile neutropenia

article Full Text OpenAlex

Red cell distribution width and clinical outcomes in sepsis patients infected with Escherichia coli using data from MIMIC-IV

article Full Text OpenAlex

Beyond Programmed Death-Ligand 1: Gut Microbiome Composition as a Biomarker For First-Line Chemoimmunotherapy in Advanced NSCLC

editorial Full Text OpenAlex

[Interaction between COVID-19 Infection and Hematological Malignancies --Review].

review Full Text OpenAlex

[The Efficacy of Combination of Avatrombopag and rhIL-11 in Adult Patients of Acute Myeloid Leukemia with Cancer Treatment-Induced Thrombocytopenia].

article Full Text OpenAlex

Non-invasive aspergillosis following COVID-19 exacerbates the severity of SARS-CoV-2 infection

preprint Full Text OpenAlex

Sa1259: IMPROVEMENT IN DISTENSIBILITY IS GREATER WITH DUPILUMAB COMPARED TO OTHER TREATMENTS IN EOE

article Full Text OpenAlex

近5年高被引文献
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events

article Full Text OpenAlex 602 FWCI50.904

Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer

article Full Text OpenAlex 245 FWCI35.572

Sepsis-Induced Immunosuppression

review Full Text OpenAlex 228 FWCI8.13

De novo acute myeloid leukemia: A population‐based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980 to 2017

article Full Text OpenAlex 187 FWCI26.233

8th European Conference on Infections in Leukaemia: 2020 guidelines for the diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or post-haematopoietic cell transplantation

review Full Text OpenAlex 170 FWCI4.406

CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trial

article Full Text OpenAlex 156 FWCI22.304

Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward

review Full Text OpenAlex 146 FWCI4.356

The association between albumin levels and survival in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis

review Full Text OpenAlex 146 FWCI6.382

Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial

article Full Text OpenAlex 118 FWCI49.257

Estimation of the Number of Individuals Living With Metastatic Cancer in the United States

article Full Text OpenAlex 117 FWCI17.561